- €1.08bn
- €3.13bn
- €2.32bn
Gerresheimer's shares fall 11% after another outlook cut
Live Markets: Before the bell: Europe steady, TSMC beats, Ferrari goes electric
Gerresheimer drops 8% in early trade after outlook cut
Brief: Gerresheimer Says It Expects A Stronger Q4 2025 Compared To Q3 2025, Mainly Due To Planned Production Ramp-Ups For Drug Delivery Systems
Gerresheimer cuts 2025 outlook again as Q3 disappoints
Brief: Gerresheimer Q3 Revenue EUR 560.7 Million
Brief: Gerresheimer Expands Wertheim Site With New Production Facility
Brief: Gerresheimer Comments On The Audit By German BaFin
Gerresheimer shares tank as financial regulator suspects accounting flaws (updated)
Germany's BaFin launches audit of Gerresheimer's 2024 group accounts
Gerresheimer CFO resigns, successor to take over from September (updated)
Gerresheimer CFO resigns unexpectedly, successor to take over from September
Brief: Gerresheimer Says Wolf Lehmann To Replace Bernd Metzner As CFO
Brief: Gerresheimer Secures Eur 200 Mln Loan For Borioli Pharma Acquisition
Activist investor wants review at Gerresheimer after taking stake (updated)
Activist investor wants review at Gerresheimer after taking stake
Brief: Gerresheimer Says AOC Gecko S.À R.L Holds 7.19% Of Total Voting Rights And Instruments In Gerresheimer AG As Of 15 Aug 2025
Factbox: Healthcare firms see growing activist investor involvement in the past year
Europe Research Roundup: Bellway, Carlsberg, Pandora